HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 274 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.48 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $42,861 | +6.2% | 1,122 | +0.3% | 0.00% | – |
Q2 2023 | $40,363 | +71.6% | 1,119 | +81.7% | 0.00% | – |
Q1 2023 | $23,526 | -23.3% | 616 | +14.3% | 0.00% | – |
Q4 2022 | $30,669 | +53.3% | 539 | +5.3% | 0.00% | – |
Q3 2022 | $20,000 | -13.0% | 512 | -2.1% | 0.00% | – |
Q2 2022 | $23,000 | +15.0% | 523 | +2.8% | 0.00% | – |
Q1 2022 | $20,000 | 0.0% | 509 | +1.8% | 0.00% | – |
Q4 2021 | $20,000 | 0.0% | 500 | 0.0% | 0.00% | – |
Q3 2021 | $20,000 | -13.0% | 500 | 0.0% | 0.00% | – |
Q2 2021 | $23,000 | +9.5% | 500 | 0.0% | 0.00% | – |
Q1 2021 | $21,000 | 0.0% | 500 | 0.0% | 0.00% | -100.0% |
Q4 2020 | $21,000 | +61.5% | 500 | 0.0% | 0.00% | – |
Q3 2020 | $13,000 | 0.0% | 500 | 0.0% | 0.00% | – |
Q2 2020 | $13,000 | +44.4% | 500 | 0.0% | 0.00% | – |
Q1 2020 | $9,000 | 0.0% | 500 | 0.0% | 0.00% | – |
Q4 2019 | $9,000 | – | 500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Security, LLC | 19,305,403 | $233,209,000 | 10.86% |
BB BIOTECH AG | 7,379,832 | $89,148,000 | 3.13% |
SENZAR ASSET MANAGEMENT, LLC | 550,544 | $6,650,572,000 | 1.72% |
SNYDER CAPITAL MANAGEMENT L P | 2,232,114 | $26,964,000 | 1.69% |
Sterling Global Strategies LLC | 22,000 | $266,000 | 0.98% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 9,290,024 | $112,223,000 | 0.98% |
MSD Partners, L.P. | 965,000 | $11,657,000 | 0.94% |
DOHENY ASSET MANAGEMENT /CA | 130,950 | $1,582,000 | 0.81% |
Taylor Wealth Management Partners | 128,110 | $1,548,000 | 0.69% |
Bellevue Group AG | 318,000 | $3,841,000 | 0.69% |